相关实验视频

Updated: Jul 25, 2025

Homogeneous Time-resolved Förster Resonance Energy Transfer-based Assay for Detection of Insulin Secretion
07:30

Homogeneous Time-resolved Förster Resonance Energy Transfer-based Assay for Detection of Insulin Secretion

Published on: May 10, 2018

9.3K

超越临床实践中的方法变化:对胰岛素样生长因子I测试的评估

Paula Sienes Bailo1, Marta Fabre Estremera1, José Cuenca Alcocel2

  • 1Department of Clinical Biochemistry, Miguel Servet University Hospital, Zaragoza, Spain; and Aragon Institute of Health Research (IIS Aragon), Zaragoza, Spain.

Advances in laboratory medicine
|June 26, 2023
PubMed
概括

针对胰岛素样生长因子I (IGF-I) 的不同测试产生了不同的结果. 与Immulite 2000XPi相比,Cobas e411测定显著高估了IGF-I,可能导致误诊.

关键词:
增长激素增长激素的使用方法免疫测试是一种免疫测试.类似胰岛素的增长因子I.方法比较方法比较

更多相关视频

Measuring Relative Insulin Secretion using a Co-Secreted Luciferase Surrogate05:58

Measuring Relative Insulin Secretion using a Co-Secreted Luciferase Surrogate

Published on: June 25, 2019

7.5K
Validated Immunochemical Assay for Comprehensive Determination of the Human Epidermal Growth Factor Receptor 2 Released from and Bound to Cells08:28

Validated Immunochemical Assay for Comprehensive Determination of the Human Epidermal Growth Factor Receptor 2 Released from and Bound to Cells

Published on: May 9, 2025

195

相关概念视频

Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
214